Wei‐Juin Su
121 works · 3,391 citations · h-index 30
Top works
- Polymorphism of the N -acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis
- Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced Hepatitis
- Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury
- Eight-Month Prospective Study of 14 Patients With Hospital-Acquired Severe Acute Respiratory Syndrome
- Sleep apnea and risk of pneumonia: a nationwide population-based study
- Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study
- Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan
- Necrotizing fasciitis: is it a fatal complication of tube thoracostomy?- Report of three cases
- Management of hospital-acquired severe acute respiratory syndrome with different disease spectrum.
- Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
- Statin Use Is Associated With a Lower Risk of TB
- Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis
- Gender Disparities in Latent Tuberculosis Infection in High-Risk Individuals: A Cross-Sectional Study
- Extralobar Pulmonary Sequestration Presenting as an Anterior Mediastinal Tumor in an Adult
- Utility of PCR assays for rapid diagnosis of BCG infection in children.
- Association between Tumor Epidermal Growth Factor Receptor Mutation and Pulmonary Tuberculosis in Patients with Adenocarcinoma of the Lungs
- Masks and medical care: Two keys to Taiwan's success in preventing COVID-19 spread
- The changing pattern of intestinal tuberculosis: 30 years' experience.
- Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression
- Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study